News

Under the agreement, Siga will receive approximately $1 million to support specific aspects of the preclinical development of Siga’s oral anti-smallpox drug Siga-246. Smallpox is considered one of

This multi-center, placebo-controlled phase III clinical trial will evaluate the safety and efficacy of Silenor over a three month period in elderly patients diagnosed with primary chronic insomnia.

The company is on track to submit the drug to US regulators in early 2006, and EU regulators later on that year. These submissions will be for SPP100

Based on 60-90 day follow-up data from the study known as Optimize-HF, beta-blocker use at hospital discharge in patients with heart failure improved treatment rates and was associated

The study, conducted at the University of California, is also the first to show the causal relationship between transplanted human neural stem cells and long-term recovery of motor

Arimidex is the only aromatase inhibitor with study results representing a full five years of efficacy and safety data in this primary adjuvant setting, and is now the

The findings suggest that the abnormal leakage of lymph fluid from the ruptured lymphatic vessels stimulates the accumulation of fat, particularly in regions of the body rich in

Theragran-M Advanced formula will return exclusively to Walgreens stores in mid-October. The multivitamin was one of the most widely used supplements and one of Walgreens best selling brands.

Of the eight patients who have completed treatment in the study, two experienced grade IV acute graft-versus-host-disease, or aGVHD, a known potential side effect in transplantation. Both patients